SCHEMBL6025873

SCHEMBL6025873

COc1ccc(C(Cl)Br)c(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
ALDH1A1 P00352 4/20 0.46
CYP1A1 P04798 4/20 0.46
CYP1A2 P05177 4/20 0.46
CYP1B1 Q16678 4/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 3/20 0.43
ADRA2A P08913 2/20 0.42
ADRA1A P35348 2/20 0.42
CYP2E1 P05181 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP4B1 P13584 1/20 0.42
CYP2B6 P20813 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27566987 0.85 CYP2D6 (0.56) CA12CA1CA2CA7CA9
SCHEMBL11439916 0.84 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL6706944 0.84 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL9730314 0.84 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL11709828 0.82 CA12 (0.54) CA12CA1CA2CA7CA9
SCHEMBL2096165 0.80 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL8785084 0.79 CA12 (0.60) CA12CA1CA2CA7CA9
SCHEMBL682768 0.78 CA12 (0.58) CA12CA1CA2CA7CA9
SCHEMBL27624871 0.77 CA12 (0.52) CA12CA1CA2CA7CA9
SCHEMBL7136589 0.77 CA12 (0.47) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670802-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS Conforma Therapeutic Corporation (US) 2006-06-21 EP disclosed
WO-2005028434-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2005-03-31 WO disclosed